(Q43296371)
Statements
Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression (English)
C Hinrichs
U Appel
N Babel
H-H Neumayer
M Dreyling
U Dührsen
V Kliem
S Schüttrumpf
I A Hauser
H-G Mergenthaler
P Schlattmann
I Anagnostopoulos
B Doerken